logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Cordycepin CAS 73-03-0 Crystalline Solid Appearance

Cordycepin CAS 73-03-0 Crystalline Solid Appearance

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 73-03-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 73-03-0 Cordycepin

,

CAS 73-03-0

CAS NO::
73-03-0
Appearance::
Crystalline Solid
Molecular Formula::
C10H13N5O3
Molecular Weight::
251.24200
EINECS NO::
200-791-4
MDL NO::
MFCD00037998
CAS NO::
73-03-0
Appearance::
Crystalline Solid
Molecular Formula::
C10H13N5O3
Molecular Weight::
251.24200
EINECS NO::
200-791-4
MDL NO::
MFCD00037998
Cordycepin CAS 73-03-0 Crystalline Solid Appearance

Product Description:

Product Name: Cordycepin CAS NO: 73-03-0

 

 

Synonyms:

(2R,3R,5S)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol;

Adenine cordyceposide;

3'-Deoxy-D-adenosine;

 

 

Chemical & Physical Properties:

Appearance: Crystalline Solid

Assay :≥99.0%

Density: 1.91 g/cm3

Boiling Point: 627.2℃ at 760 mmHg

Melting Point: 225-229℃

Flash Point: 333.1℃

Refractive Index: 1.863

Storage Condition: -20℃

 

 

Safety Information:

RTECS: AU7358610

Safety Statements: S26-S45

HS Code: 29349990

WGK Germany: 3

RIDADR: UN 2811

Risk Statements: R25; R36/37/38

Hazard Codes: T,Xn

 

 

Cordycepin, or 3'-deoxyadenosine, is a derivative of the nucleoside adenosine, differing from the latter by the absence of the hydroxy group in the 3' position of its ribose part. It was initially extracted from the fungus Cordyceps militaris, but is now produced synthetically.

Because cordycepin is similar to adenosine, some enzymes cannot discriminate between the two. Therefore, it can participate in certain biochemical reactions (for example, be incorporated into an RNA molecule, thus causing the premature termination of its synthesis).

Cordycepin has displayed cytotoxicity against some leukemic cell lines in vitro, and at least one clinical trial of cordycepin as a leukemia treatment is in progress.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.